Citigroup Inc. Upgrades Johnson & Johnson to “Buy” (JNJ)
Johnson & Johnson (NYSE:JNJ) was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Thursday, Analyst Ratings Network reports.
Johnson & Johnson (NYSE:JNJ) traded up 0.08% during mid-day trading on Thursday, hitting $94.24. The stock had a trading volume of 3,448,428 shares. Johnson & Johnson has a 52 week low of $71.74 and a 52 week high of $95.99. The stock has a 50-day moving average of $93.17 and a 200-day moving average of $90.81. The company has a market cap of $265.9 billion and a price-to-earnings ratio of 21.00.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, March 11th. Shareholders of record on Tuesday, February 25th will be given a dividend of 0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 2.80%. The ex-dividend date of this dividend is Friday, February 21st.
A number of other analysts have also recently weighed in on JNJ. Analysts at Goldman Sachs Group Inc. raised their price target on shares of Johnson & Johnson from $46.00 to $50.00 in a research note to investors on Thursday. They now have a “neutral” rating on the stock. Separately, analysts at Jefferies Group upgraded shares of Johnson & Johnson from a “hold” rating to a “buy” rating in a research note to investors on Thursday. They now have a $108.00 price target on the stock, up previously from $5.84. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and nine have given a buy rating to the company. Johnson & Johnson has a consensus rating of “Hold” and a consensus target price of $81.20.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.